P27708 (PYR1_HUMAN) Homo sapiens (Human)
CAD protein UniProtKBInterProSTRINGInteractive Modelling
2225 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Sequence Features
| 252 | Nucleophile; for GATase activity | ||
| 336 | For GATase activity | ||
| 338 | For GATase activity | ||
| 668 | Magnesium or manganese 1 | ||
| 682 | Magnesium or manganese 1 | ||
| 682 | Magnesium or manganese 2 | ||
| 684 | Magnesium or manganese 2 | ||
| 1202 | Magnesium or manganese 3 | ||
| 1214 | Magnesium or manganese 3 | ||
| 1214 | Magnesium or manganese 4 | ||
| 1216 | Magnesium or manganese 4 | ||
| 1471 | Zinc 1; via tele nitrogen | ||
| 1471 | Zinc 2; via pros nitrogen | ||
| 1473 | Zinc 1; via tele nitrogen | ||
| 1556 | Zinc 1; via carbamate group | ||
| 1556 | Zinc 3; via carbamate group | ||
| 1590 | Zinc 3; via pros nitrogen | ||
| 1613 | Zinc 2 | ||
| 1614 | Zinc 3; via tele nitrogen | ||
| 1637 | Zinc 2 | ||
| 1686 | Zinc 1 | ||
| 33 | M -> R (in EIEE50; unknown pathological significance; dbSNP:rs751610198) VAR_078289 dbSNP | ||
| 177 | R -> Q (in a colorectal cancer sample; somatic mutation; dbSNP:rs374122292) VAR_035897 dbSNP | ||
| 735 | Y -> C (in a colorectal cancer sample; somatic mutation) VAR_035898 | ||
| 2024 | R -> Q (in EIEE50; dbSNP:rs763410987) VAR_073955 dbSNP | ||
| 545-600 | ATP | ||
| 1078-1135 | ATP | ||
| 1789-2225 | Missing (in EIEE50; unknown pathological significance) VAR_078290 | ||
| 2-137 | Carbamoyl-phosphate synthase small subunit, N-terminal domain IPR002474PF00988 | ||
| 180-355 | Glutamine amidotransferase IPR017926PF00117 | ||
| 514-717 | Carbamoyl-phosphate synthetase large subunit-like, ATP-binding domain IPR005479PF02786 | ||
| 801-877 | Carbamoyl-phosphate synthetase, large subunit oligomerisation domain IPR005480PF02787 | ||
| 1050-1247 | Carbamoyl-phosphate synthetase large subunit-like, ATP-binding domain IPR005479PF02786 | ||
| 1327-1427 | Methylglyoxal synthase-like domain IPR011607PF02142 | ||
| 1464-1524 | Amidohydrolase-related IPR006680PF01979 | ||
| 1924-2065 | Aspartate/ornithine carbamoyltransferase, carbamoyl-P binding IPR006132PF02729 | ||
| 2072-2220 | Aspartate/ornithine carbamoyltransferase, Asp/Orn-binding domain IPR006131PF00185 |
Sequence Alignments
Experimental structures
| Description | Oligo-state | Ligands | Structure | Range |
|---|---|---|---|---|
| Aspartate transcarbamoylase domain of human CAD in apo form | homo-3-mer | 3×EDO; 1×GOL; | 5g1o | |
| Assess | ||||
| Aspartate transcarbamoylase domain of human CAD bound to carbamoyl phosphate | homo-3-mer | 3×CP; | 5g1p | |
| Assess | ||||
| Aspartate transcarbamoylase domain of human CAD bound to PALA | homo-3-mer | 3×PAL; 2×EDO; | 5g1n | |
| Assess | ||||
| Crystal structure of the dihydroorotase domain of human CAD with incomplete active site, obtained r… | homo-2-mer | 10×FMT; 2×GOL; | 4c6b | |
| Assess | ||||
| Crystal structure of the dihydroorotase domain of human CAD bound to substrate at pH 6.5 | homo-2-mer | 2×DOR; 2×NCD; 8×ZN; 8×FMT; | 4c6f | |
| Assess | ||||
| Crystal structure of the dihydroorotase domain of human CAD bound to substrate at pH 5.5 | homo-2-mer | 2×DOR; 2×NCD; 4×ZN; 8×FMT; | 4c6e | |
| Assess | ||||
| Hybrid dihydroorotase domain of human CAD with E. coli flexible loop, bound to dihydroorotate | homo-2-mer | 6×FMT; 4×ZN; 2×DOR; | 6hg3 | |
| Assess | ||||
| Crystal structure of the dihydroorotase domain of human CAD bound to substrate at pH 7.5 | homo-2-mer | 6×ZN; 2×DOR; 2×NCD; 6×FMT; | 4c6j | |
| Assess | ||||
| Crystal structure of the dihydroorotase domain of human CAD bound to substrate at pH 7.0 | homo-2-mer | 6×ZN; 6×FMT; 2×DOR; 2×NCD; | 4c6i | |
| Assess | ||||
| Human dihydroorotase mutant F1563A co-crystallized with carbamoyl aspartate at pH 7.0 | homo-2-mer | 8×ZN; 6×FMT; 2×DOR; | 6hfh | |
| Assess | ||||
| Crystal structure of the dihydroorotase domain of human CAD bound to substrate at pH 8.0 | homo-2-mer | 6×ZN; 2×NCD; 6×FMT; 2×DOR; | 4c6k | |
| Assess | ||||
| Crystal structure of the dihydroorotase domain of human CAD bound to the inhibitor fluoroorotate at… | homo-2-mer | 4×ZN; 4×FMT; 2×FOT; | 4c6l | |
| Assess | ||||
| Crystal structure of the dihydroorotase domain of human CAD bound to the inhibitor fluoroorotate at… | homo-2-mer | 6×ZN; 4×FMT; 2×FOT; | 4c6m | |
| Assess | ||||
| Crystal structure of the dihydroorotase domain of human CAD C1613S mutant bound to substrate at pH … | homo-2-mer | 2×ORO; 4×ZN; 2×NCD; 8×FMT; | 4c6q | |
| Assess | ||||
| Crystal structure of the dihydroorotase domain of human CAD E1637T mutant bound to substrate at pH … | homo-2-mer | 4×ZN; 6×FMT; 2×NCD; | 4c6n | |
| Assess | ||||
| Human dihydroorotase mutant F1563A co-crystallized with carbamoyl aspartate at pH 7.5 | homo-2-mer | 8×ZN; 6×FMT; 2×DOR; | 6hfj | |
| Assess | ||||
| Crystal structure of the dihydroorotase domain of human CAD bound to substrate at pH 6.0 | homo-2-mer | 2×DOR; 2×NCD; 8×ZN; 8×FMT; | 4c6d | |
| Assess | ||||
| Human dihydroorotase mutant F1563Y co-crystallized with carbamoyl aspartate at pH 7.0 | homo-2-mer | 8×ZN; 2×NCD; 6×FMT; | 6hfr | |
| Assess | ||||
| Human dihydroorotase mutant F1563Y co-crystallized with carbamoyl aspartate at pH 6.5 | homo-2-mer | 8×ZN; 2×NCD; 6×FMT; | 6hfs | |
| Assess | ||||
| Human dihydroorotase mutant F1563L co-crystallized with carbamoyl aspartate at pH 7.0 | homo-2-mer | 8×ZN; 2×DOR; 6×FMT; | 6hfl | |
| Assess | ||||
| Human dihydroorotase mutant F1563Y co-crystallized with carbamoyl aspartate at pH 7.5 | homo-2-mer | 6×ZN; 2×NCD; 6×FMT; | 6hfu | |
| Assess | ||||
| Crystal structure of the dihydroorotase domain of human CAD in apo- form obtained recombinantly fro… | homo-2-mer | 8×ZN; 8×FMT; | 4c6c | |
| Assess | ||||
| Human dihydroorotase mutant F1563L co-crystallized with carbamoyl aspartate at pH 6.5 | homo-2-mer | 8×ZN; 6×FMT; 2×DOR; | 6hfk | |
| Assess | ||||
| Human dihydroorotase mutant F1563A apo structure | homo-2-mer | 8×ZN; 10×FMT; | 6hfi | |
| Assess | ||||
| Human dihydroorotase mutant F1563T apo structure | homo-2-mer | 8×ZN; 12×FMT; | 6hfe | |
| Assess | ||||
| Human dihydroorotase mutant F1563Y apo structure | homo-2-mer | 8×ZN; 8×FMT; | 6hff | |
| Assess | ||||
| Crystal structure of the dihydroorotase domain of human CAD C1613S mutant in apo-form at pH 7.0 | homo-2-mer | 6×ZN; 8×FMT; | 4c6p | |
| Assess | ||||
| Crystal structure of the dihydroorotase domain of human CAD C1613S mutant in apo-form at pH 6.0 | homo-2-mer | 4×ZN; 8×FMT; | 4c6o | |
| Assess | ||||
| Crystal structure of the dihydroorotase domain of human CAD in apo- form obtained recombinantly fro… | homo-2-mer | 8×ZN; 8×FMT; | 4by3 | |
| Assess | ||||
| Hybrid dihydroorotase domain of human CAD with E. coli flexible loop, bound to fluoroorotate | homo-2-mer | 4×ZN; 2×FOT; 2×FMT; | 6hg2 | |
| Assess | ||||
| Human dihydroorotase mutant F1563L apo structure | homo-2-mer | 8×ZN; 8×FMT; | 6hfd | |
| Assess | ||||
| Hybrid dihydroorotase domain of human CAD with E. coli flexible loop in apo state | monomer | 2×ZN; 4×FMT; | 6hg1 | |
| Assess | ||||
| Crystal structure of the dihydroorotase domain (K1556A) of human CAD | monomer | 1×ZN; | 5ynz | |
| Assess | ||||
| Human dihydroorotase mutant F1563T co-crystallized with carbamoyl aspartate at pH 7.5 | monomer | 4×ZN; 1×DOR; 4×FMT; 1×GOL; | 6hfq | |
| Assess | ||||
| Human dihydroorotase mutant F1563T co-crystallized with carbamoyl aspartate at pH 7.0 | monomer | 4×ZN; 1×DOR; 4×FMT; | 6hfp | |
| Assess | ||||
| Human dihydroorotase mutant F1563L co-crystallized with carbamoyl aspartate at pH 7.5 | monomer | 3×ZN; 3×FMT; 1×DOR; | 6hfn | |
| Assess | ||||
Homology models
| Oligo-state | QMEAN | Template | Range | Seq id (%) | Ligands |
|---|---|---|---|---|---|
| homo-2-mer | -1.20 | 5dou.1.A | 52.01 | 5×MG; 4×K; | |
| Assess | |||||